🇺🇸 Daricon in United States

Daricon (OXYPHENCYCLIMINE) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: NDA011612
  • Marketing authorisation holder: PFIZER
  • Local brand name: DARICON
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Daricon in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Daricon approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for Daricon in United States?

Marketing authorisation holder not available in our data.